Colan Totte.Co.,Ltd. risk profile
19 Contained slack in every measured input
Measured 21 October 2026 from 7792.T's filed statements. Recomputed nightly.
19 (Contained), driven by Cash conversion at 40, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 26 | Normal | Stable | One-year price volatility — 20.0% |
| Operating pressure | 33 | Normal | Worsening | Costs outgrowing revenue — -1.4 percentage points |
| Cash conversion | 40 | Elevated | Easing | Cash conversion — 0.75x |
| Leverage and coverage | 6 | Contained | Stable | Current ratio — 3.16x |
| Competitive position | 10 | Contained | Stable | Revenue-growth gap against peers — +32.5 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Healthcare companies with a risk reading
Lilly(Eli) & Company 33Johnson & Johnson 39Abbvie Inc 57Unitedhealth Group Inc 43Roche Holding AG 35Merck & Co Inc 35Novartis AG 29Novartis AG 31Astrazeneca plc 33Thermo Fisher Scientific Inc 44AMGEN Inc 47Gilead Sciences Inc 51
Financials, valuation and price history for Colan Totte.Co.,Ltd.